Caseinolytic protease: a protein vaccine which could elicit serotype‐independent protection against invasive pneumococcal infection

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical and Experimental Immunology

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2249.2008.03866.xPMID 19220325PMCID PMC2673741
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization

  2008cited by this paper
• Streptococcus pneumoniae: proteomics of surface proteins for vaccine development.

  2008cited by this paper
• Invasive pneumococcal disease and the potential for prevention by vaccination in the United Kingdom.

  2007cited by this paper
• Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children.

  2007cited by this paper
• The introduction of new vaccines into developing countries. IV: Global Access Strategies.

  2007cited by this paper
• Vaccine Escape Recombinants Emerge after Pneumococcal Vaccination in the United States

  2007cited by this paper
• Serum Amyloid P Aids Complement-Mediated Immunity to Streptococcus pneumoniae

  2007cited by this paper
• The preventable burden of pneumococcal disease in the developing world.

  2007cited by this paper
• Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.

  2007cited by this paper
• Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003.

  2006cited by this paper
• Development of a Vaccine against Invasive Pneumococcal Disease Based on Combinations of Virulence Proteins of Streptococcus pneumoniae

  2006cited by this paper
• The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design

  2006cited by this paper
• Antibody-Independent, Interleukin-17A-Mediated, Cross-Serotype Immunity to Pneumococci in Mice Immunized Intranasally with the Cell Wall Polysaccharide

  2006cited by this paper
• A pneumococcal pilus influences virulence and host inflammatory responses.

  2006cited by this paper
• Antibiotic Stress Induces Genetic Transformability in the Human Pathogen Streptococcus pneumoniae

  2006cited by this paper
• Relationship between Surface Accessibility for PpmA, PsaA, and PspA and Antibody-Mediated Immunity to Systemic Infection by Streptococcus pneumoniae

  2005cited by this paper
• Contribution of the ATP-Dependent Protease ClpCP to the Autolysis and Virulence of Streptococcus pneumoniae

  2005cited by this paper
• CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.

  2005cited by this paper
• Tissue-specific contributions of pneumococcal virulence factors to pathogenesis.

  2004cited by this paper
• Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel.

  2004cited by this paper
• The Virulence Function of Streptococcus pneumoniae Surface Protein A Involves Inhibition of Complement Activation and Impairment of Complement Receptor-Mediated Protection1

  2004cited by this paper
• The ClpP Protease of Streptococcus pneumoniae Modulates Virulence Gene Expression and Protects against Fatal Pneumococcal Challenge

  2004cited by this paper
• Streptococcus pneumoniae and its bacteriophages: one long argument.

  2004cited by this paper
• Streptococcus pneumoniae colonisation: the key to pneumococcal disease.

  2004cited by this paper
• Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children.

  2004cited by this paper
• Microarray Analysis of Pneumococcal Gene Expression during Invasive Disease

  2004cited by this paper
• Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential.

  2003cited by this paper
• Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study.

  2003cited by this paper
• Pneumococcal conjugate vaccines: proceedings from an interactive symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy.

  2003cited by this paper
• The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo.

  2002cited by this paper
• Nasal mucosal temperature during respiration.

  2002cited by this paper
• Global Transcriptional Analysis of clpP Mutations of Type 2 Streptococcus pneumoniae and Their Effects on Physiology and Virulence

  2002cited by this paper
• Role of Pneumococcal Surface Protein C in Nasopharyngeal Carriage and Pneumonia and Its Ability To Elicit Protection against Carriage of Streptococcus pneumoniae

  2002cited by this paper
• Genetic Immunization with the Region Encoding the α-Helical Domain of PspA Elicits Protective Immunity againstStreptococcus pneumoniae

  2001cited by this paper
• Regulation of Streptococcus pneumoniae clp Genes and Their Role in Competence Development and Stress Survival

  2001cited by this paper
• Pneumococcal Carriage in Children in The Netherlands: a Molecular Epidemiological Study

  2001cited by this paper
• Protection against Streptococcus pneumoniae Elicited by Immunization with Pneumolysin and CbpA

  2001cited by this paper
• Prevention of pneumococcal disease by vaccination: does serotype replacement matter?

  2000cited by this paper
• Diversity of PspA: Mosaic Genes and Evidence for Past Recombination in Streptococcus pneumoniae

  2000cited by this paper
• Role of Heat Shock Proteins in Protection from and Pathogenesis of Infectious Diseases

  1999cited by this paper
• Posttranslational quality control: folding, refolding, and degrading proteins.

  1999cited by this paper
• The pspC Gene of Streptococcus pneumoniae Encodes a Polymorphic Protein, PspC, Which Elicits Cross-Reactive Antibodies to PspA and Provides Immunity to Pneumococcal Bacteremia

  1999cited by this paper
• Emergence of vancomycin tolerance in Streptococcus pneumoniae

  1999cited by this paper
• Nasopharyngeal colonization of infants in southern India with Streptococcus pneumoniae

  1999cited by this paper
• Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae.

  1997cited by this paper
• C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity

  1996cited by this paper
• Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA

  1994cited by this paper
• Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins.

  1993cited by this paper
• Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae

  1981cited by this paper
• In the United States

  1921cited by this paper

• Pathogenicity and virulence of Streptococcus pneumoniae: Cutting to the chase on proteases

  2021cites this paper
• A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge

  2018cites this paper
• Corrected and Republished from: “A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge”

  2018cites this paper
• Dendritic cell‐targeting DNA‐based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae

  2017cites this paper
• Glycoconjugate vaccines: an update

  2015cites this paper
• Phenotypic and genotypic analysis of Streptococcus pneumoniae diversity during the introduction of pneumococcal conjugate vaccines in the UK

  2014cites this paper
• Streptococcus pneumoniae , a capsulated lancet-shaped gram-positive bacterium is a leading cause of morbidity and mortality among children all over the world and a major cause of diseases such as pneumonia , meningitis and sepsis

  2014cites this paper
• Recent Approaches in Vaccine Development against Streptococcus pneumoniae

  2014cites this paper
• Bacterial proteases and virulence.

  2013cites this paper
• Pneumococcal ClpP modulates the maturation and activation of human dendritic cells: implications for pneumococcal infections

  2013cites this paper
• Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice

  2012cites this paper
• Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults

  2012cites this paper
• Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview

  2012cites this paper
• Immunization with DnaJ (hsp40) could elicit protection against nasopharyngeal colonization and invasive infection caused by different strains of Streptococcus pneumoniae.

  2011cites this paper
• Stress Responses of Streptococci

  2011cites this paper
• Continued control of pneumococcal disease in the UK - the impact of vaccination.

  2011cites this paper
• Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis‐PppA induces effective protection against pneumoccocal infection in young mice

  2010cites this paper
• Lactococcus lactis as an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infections

  2010cites this paper
• Two Spx proteins modulate stress tolerance , survival , 4 and virulence in Streptococcus mutans 5 6 7

  2010cites this paper
• Periodicity of Epidemics of Invasive Disease due to Infection With Streptococcus pneumoniae in the United States

  2010cites this paper
• Two Spx Proteins Modulate Stress Tolerance, Survival, and Virulence in Streptococcus mutans

  2010cites this paper
• Should patients with chronic obstructive pulmonary disease be vaccinated against pneumococcal diseases?

  2009cites this paper